Banque Transatlantique SA Invests $1.28 Million in HCA Healthcare, Inc. $HCA

Key Points

• Banque Transatlantique SA has taken a $1.28 million position in HCA Healthcare, acquiring 3,999 shares in the 1st quarter, indicating growing institutional interest in the company.
• HCA Healthcare's latest quarterly earnings surpassed analyst expectations, reporting $6.84 earnings per share and $18.61 billion in revenue, marking a 6.4% increase year-over-year.
• Several analysts have varied ratings for HCA shares, with a current average rating of "Moderate Buy" and a price target averaging $401.83.

Banque Transatlantique SA acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 3,999 shares of the company's stock, valued at approximately $1,277,000.

Several other hedge funds have also recently bought and sold shares of the company. AQR Capital Management LLC increased its holdings in HCA Healthcare by 54.3% in the 1st quarter. AQR Capital Management LLC now owns 239,532 shares of the company's stock valued at $82,421,000 after buying an additional 84,260 shares during the period. Abdiel Capital Advisors LP bought a new position in HCA Healthcare in the 1st quarter valued at about $164,835,000. Adage Capital Partners GP L.L.C. increased its holdings in HCA Healthcare by 131.7% in the 1st quarter. Adage Capital Partners GP L.L.C. now owns 172,633 shares of the company's stock valued at $59,653,000 after buying an additional 98,112 shares during the period. Federation des caisses Desjardins du Quebec grew its holdings in shares of HCA Healthcare by 18.6% during the 1st quarter. Federation des caisses Desjardins du Quebec now owns 18,120 shares of the company's stock valued at $6,262,000 after purchasing an additional 2,846 shares during the last quarter. Finally, First Manhattan CO. LLC. grew its holdings in shares of HCA Healthcare by 32.3% during the 1st quarter. First Manhattan CO. LLC. now owns 16,166 shares of the company's stock valued at $5,586,000 after purchasing an additional 3,951 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 2.2%

Shares of HCA Healthcare stock traded up $9.09 during trading on Friday, reaching $420.68. 1,059,770 shares of the company traded hands, compared to its average volume of 1,054,336. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $420.98. The company has a 50 day moving average price of $380.14 and a 200-day moving average price of $359.85. The firm has a market capitalization of $98.44 billion, a PE ratio of 17.68, a P/E/G ratio of 1.29 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Morgan Stanley cut their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Wells Fargo & Company cut their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 14th. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, August 26th. Finally, Royal Bank Of Canada cut their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.